Streetbeat News

Products Services

ALGOUSD

Matt Keller, Head of Social Impact for the Algorand Foundation, will be speaking at Benzinga's Future of Digital Assets conference on Nov. 14. Keller is known for driving social transformation through technology, specifically leveraging the Algorand blockchain. His work focuses on financial inclusion, social impact, and environmental sustainability. The conference session will discuss emerging trends, innovative applications, and potential upheavals to traditional centralized models in the realm of the decentralized web.

Portfolio Pulse from Murtuza Merchant

October 12, 2023 | 12:44 pm

WBA

Walgreens' Interim CEO announced that the company is reducing areas for contracted or project work, altering store operating hours based on local market trends, closing unprofitable stores, and using AI to more accurately forecast demand.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:43 pm

CYRX

Cryoport, Inc. (NASDAQ:CYRX) has signed a three-year supply chain solutions agreement with Monash IVF Group Limited, a leading provider of assisted reproductive services in Australia and Southeast Asia. Monash IVF and its operating businesses will utilize Cryoport's cryogenic logistics solutions and ISO-certified risk mitigation process for the delivery of patients' reproductive materials throughout Australia and internationally.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:41 pm

HCA

HCA Healthcare's Johnston-Willis Hospital in Richmond, Virginia, is the first in the U.S. to provide treatment in a new clinical trial for patients with brain metastases from lung cancer. The trial, conducted by HCA Healthcare Research Institute and sponsored by Insightec, uses noninvasive focused ultrasound with systemic immunotherapy. The treatment uses Insightec's system to open the blood-brain barrier (BBB), allowing non-small cell lung cancer medications to reach and target the critical lesions in the brain. The trial is expected to last through August 2024.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:41 pm

CLOV

Clover Health has issued an analysis showing that the use of its Clover Assistant technology is associated with earlier identification and management of diabetes. The technology synthesizes large volumes of data from disparate sources and provides key clinical insights to clinicians. The analysis also showed that the use of Clover Assistant resulted in lower blood sugar, insulin use, and hypoglycemia.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:40 pm

CDIO

Cardio Diagnostics Holdings has launched a new lab and fulfillment center in Iowa City, Iowa. The new facility will enhance the company's capacity to deliver its services.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:39 pm

GCTK

Glucotrack, Inc. (NASDAQ:GCTK) has commenced preclinical animal testing for its implantable continuous glucose monitor (CGM). The company previously announced positive results from a laboratory-based feasibility study. The preclinical study established that the sensor implant procedure takes approximately 15-20 minutes to perform, does not require sophisticated implant techniques or tools, and had no adverse short-term or long-term effect on the animals. Long-term preclinical studies on sensor performance are expected to start in late Q4 of this year.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:37 pm

DVA

DaVita Inc. has issued a statement in response to Novo Nordisk's FLOW study on Ozempic, a drug for type 2 diabetes, which aims to show that it delays the progression of chronic kidney disease (CKD) and lowers the risk of kidney and cardiovascular mortality. DaVita's chief medical officer, Dr. Jeff Giullian, stated that while it's too early to draw conclusions from the study, they believe its findings may have limited application to the overall CKD patient population. Novo Nordisk plans to release the FLOW study in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:36 pm

DSS

PRPH

DSS, Inc. has issued a letter to shareholders providing an update on the company's progress and future expectations. The company is preparing for an IPO of its majority-owned subsidiary, Impact Biomedical, Inc. (IBIO). DSS's product packaging division, Premier Packaging Corporation, Inc., reported a 27% increase in revenue for the first half of 2023. DSS Wealth Management, Inc. has enhanced its management team and plans to launch a Total Return Bond Fund. The company also plans to introduce shareholders to subsequent spinoffs or similar liquidity events after the Impact Biomedical IPO.

Portfolio Pulse from Happy Mohamed

October 12, 2023 | 12:28 pm

AAPL

META

Fitness app developer Andre Elijah has filed a lawsuit against Meta Platforms Inc. (NASDAQ:META) alleging that his AEI Fitness app project was abruptly canceled just days before its scheduled launch. Elijah is seeking $3.2 million in immediate damages and hundreds of millions more in lost revenue. The lawsuit also names Zuckerberg and Alo, a Beverly Hills fitness apparel and accessories company, as defendants. This lawsuit comes at a time when competition in the VR headset market is intensifying, with Apple Inc. (NASDAQ:AAPL) set to launch its Apple Vision Pro for sale in early 2024.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 12:16 pm